Cited by 318Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthAlzheimer's disease research and treatments

Human Apolipoprotein E4 Domain Interaction

Open access
Dong, Li-Ming, Weisgraber, Karl H.·1996·Journal of Biological Chemistry

Abstract

Human apolipoprotein (apo) E contains an amino- and a carboxyl-terminal domain, which are connected by a hinge region (approximately residues 165 to 215). The interaction of the two domains has been suggested to be responsible for the apoE4-binding preference for very low density lipoproteins (VLDL). In the absence of this interaction in apoE3, the preference is for high density lipoproteins (HDL). To exclude the possibility that the interaction of apoE with other apolipoproteins on the native particles may contribute to the isoform-specific preferences, VLDL-like emulsion particles were incubated with apoE, and the lipid-bound apoE was separated from free apoE on a Superose 6 column. The apoE4 bound more effectively to these particles than did apoE3, indicating that the apoE4 preference for VLDL is due not to interactions with other apolipoproteins but to an intrinsic property of apoE4, likely related to domain interaction. Previously, arginine 61 was shown to be critical for the isoform preferences, suggesting that it interacted with an acidic residue(s) in the carboxyl terminus. Substitution of arginine 61 with lysine did not alter the preference of apoE4 for VLDL, demonstrating that a positive charge rather than a specific requirement for arginine is critical for domain interaction. To identify the acidic residue(s) in the carboxyl terminus interacting with arginine 61, the six acidic residues (244, 245, 255, 266, 270, and 271) in a region known to be important for both lipoprotein association and isoform-specific preferences were substituted individually with alanine in apoE4. Only substitution of glutamic acid 255 altered the preference of apoE4 from VLDL to HDL, indicating that this was the sole residue in the carboxyl terminus that interacts with arginine 61. The participation of the hinge region in domain interaction was examined with internal deletion mutants. Deletion of the residues 186-202 or 186-223, representing major portions of the hinge region, had no effect on the apoE4 preference for VLDL. This suggests that the hinge region may act as a spacer that connects the two domains. Further deletion into the carboxyl-terminal domain (to residue 244) results in a loss of apoE4 VLDL binding. These studies establish that interaction of arginine 61 and glutamic acid 255 mediates apoE4 domain interaction.

Integrity signals

Registry

Crossref · 10.1074/jbc.271.32.19053

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 47 · Cited by 318

Authors
Dong, L.-M., & Weisgraber, K. H.
Affiliations
University of California, San Francisco (US)
Corresponding author
Weisgraber, Karl H.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1996-08
Volume
271
Issue
32
Pages
19053-19057
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2067160010
Cited by
318
References
47
Citations by year
2026: 11 · 2025: 17 · 2024: 8 · 2023: 8 · 2022: 12 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 15 · 2016: 12 · 2015: 6 · 2014: 13 · 2013: 11 · 2012: 13
FWCI
8.31
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
APOE ε4, apolipoprotein E3, VLDL, high-density lipoprotein, hinge region, C-terminal domain, N-terminal domain, domain interactions, acidic residues, point mutations, deletion mutants
MeSH terms
Apolipoproteins E, Arginine, Humans, Lipoproteins, VLDL, Protein Binding, Mutagenesis, Site-Directed, Sequence Deletion, Glutamic Acid, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review